How Food, Medicine, and Vaccines Stay Cold in Transit

TL;DR. A flu shot at a pharmacy and a bag of frozen peas at a grocery store both traveled the same basic way: through an unbroken sequence of refrigerated trucks, warehouses, and storage units, each one handing off to the next without ever letting the product warm past a set limit. That sequence is called the cold chain, and its defining trait is that a single broken link anywhere along the way can ruin the whole shipment, often without anyone noticing until later. Groceries just taste worse or get tossed. Vaccines and biologic drugs can quietly lose potency while looking, smelling, and appearing completely normal, which is why the pharmaceutical side of this system is wrapped in far more monitoring, paperwork, and law than the food side ever needed, and why the 2020 push to distribute an mRNA vaccine that needed to stay near dry-ice temperatures turned into one of the largest logistics projects of the decade.

Key takeaways

  • "Cold chain" means an unbroken sequence of temperature-controlled storage and transport from the point of manufacture to the point of use. It fails the moment any single link, a truck, a warehouse, a clinic fridge, drifts outside its target range for too long.
  • Three temperature bands cover almost everything: standard refrigeration (2 to 8 degrees Celsius) for most vaccines and many drugs, frozen (-18C or colder) for frozen food, and ultra-cold (-60C to -80C) for a small number of products, most famously the original Pfizer-BioNTech COVID-19 vaccine.
  • A spoiled vaccine usually looks, smells, and injects exactly like a good one. That single fact is why pharmaceutical cold chains lean on chemical indicators, electronic data loggers, and legally mandated paperwork that food shipments mostly don't need.
  • The 2020 to 2021 scramble to build ultra-cold freezer capacity for mRNA vaccines was a real, well-documented engineering and logistics project, and the infrastructure gap it exposed between wealthy and lower-income countries shaped how fast, and how unevenly, the world got vaccinated.
  • UNICEF alone ships close to three billion vaccine doses a year, almost entirely by air, and the global cold chain logistics market as a whole was valued at roughly 370 to 430 billion dollars in the mid-2020s.
  • The system's most common failure isn't dramatic. It's a freezer door left ajar, a cleaner unplugging the wrong cord, or a truck's refrigeration unit quietly drifting out of range for a few hours before anyone checks the log.

The moment nobody thinks about

A pharmacist swabs your upper arm, pulls a prefilled syringe from a small countertop refrigerator, and gives you a flu shot or a shingles booster in about four seconds of actual needle time. Or: you walk past the frozen aisle of a grocery store, open a fogged glass door, and drop a bag of peas or a box of fish sticks into your cart, cold enough to feel through the bag. Neither moment registers as a logistics event. It's just a shot, or a grocery run.

But from the moment that vaccine left a manufacturing plant, or that fish was caught and processed, until the instant it reached you, it sat inside a band of temperature only a few degrees wide, maintained continuously across possibly ten thousand miles, several countries, and half a dozen changes of vehicle and custody. If that band had been broken for too long at any single point along the way, and nobody caught it, you might never know. A vaccine that has lost potency to heat doesn't turn a different color or smell wrong. It just doesn't work as well, or at all, and the failure shows up later, if it shows up at all, as a case of a disease the shot was supposed to prevent. That asymmetry, between how invisible a cold chain failure is and how much it can matter, is the reason this entire system exists in the elaborate form it does.

Earlier chapters in this part of the book followed similar threads at a smaller scale: a piece of fruit's own refrigerated journey from a farm to a supermarket, and the compression cycle running quietly behind a home refrigerator's back panel. This chapter picks up that same idea, an unbroken run of cold, and follows it into a version of the system where the cost of failure isn't a soft tomato. It's a wasted dose, or a useless one given to someone who believed it would work.

What "cold chain" actually means

A cold chain is any unbroken sequence of temperature-controlled storage and transport that keeps a perishable product within a defined range from the moment it's made until the moment it's used or consumed. The word "chain" is doing real work in that definition: a chain is only as strong as its weakest link, and a cold chain is only as reliable as its worst single hour. Ten days of perfect refrigeration followed by four hours on a loading dock in direct sun can undo the whole thing, depending on the product and how sensitive it is.

Almost everything that needs this kind of handling falls into one of three temperature bands.

Standard refrigeration, roughly 2 to 8 degrees Celsius (36 to 46 Fahrenheit), covers most vaccines and a large share of injectable and biologic drugs, along with fresh food that isn't frozen. This is the range a typical home refrigerator, and a typical pharmacy or clinic vaccine fridge, is set to hold.

Frozen, -18C (0F) or colder, is the standard for frozen food (the U.S. FDA's guidance is that food held continuously at 0F or below stays safe indefinitely) and for a number of vaccines and biologics that are freeze- dried or use live viral strains, some of which are stored colder still, down around -15C to -25C.

Ultra-cold, -60C to -80C, is a much smaller category, and it existed for years mostly in specialized research and biobanking freezers before it became a household phrase. The original Pfizer-BioNTech COVID-19 vaccine needed exactly this range, because the fragile messenger RNA (mRNA) at its core, wrapped in an equally fragile lipid nanoparticle shell, degrades much faster at ordinary freezer temperatures than at ultra-cold ones. Later formulations of the same vaccine, and later data on how the original one actually held up, relaxed that requirement considerably, which is its own story below.

Watching a shipment's temperature is a separate problem from setting the target range, solved with a few different tools depending on the stakes. A data logger is a small electronic device that records temperature at set intervals, commonly every 30 minutes, throughout a trip or inside a storage unit, producing a record that can be checked after the fact or, on newer units, streamed out live. A vaccine vial monitor (VVM), developed through a decades-long collaboration between the health nonprofit PATH, the World Health Organization, and the manufacturer Temptime, and first used commercially on oral polio vaccine in 1996, is a small heat-sensitive sticker attached directly to the vial itself. Its inner square darkens irreversibly, faster in heat, and once that square matches or darkens past the reference ring printed around it, the guidance is unambiguous: the vaccine has absorbed too much cumulative heat and must be discarded, no matter what a thermometer nearby says the air happens to be right now. And increasingly, IoT sensors (small networked devices using the "internet of things," ordinary cellular or satellite links, to report data continuously rather than waiting for someone to plug them in later) sit inside modern reefer trucks and containers, streaming live temperature, humidity, location, and door-open events back to a monitoring dashboard while the shipment is still moving.

Don't be confused: a vaccine vial monitor and a data logger are not measuring the same thing. A data logger measures the air temperature inside a box, room, or truck, on the assumption that the product inside experienced roughly the same conditions. A VVM is stuck directly onto the vial itself and reacts to the actual cumulative heat that specific vial absorbed, which is a more direct measurement but only covers heat, not freezing damage. Serious cold chain operations use both: the logger tells you what the environment did, the VVM tells you what happened to the product that was actually sitting inside it.

The complete journey

Manufacturing and initial cold storage. A vaccine or drug leaves its production facility already refrigerated or frozen, typically packed into insulated cartons alongside data loggers, and moves into a temperature- controlled warehouse designed and validated (tested and documented to prove it holds its target range even during a power blip or a hot summer day) for pharmaceutical storage.

Refrigerated trucking. Over land, the workhorse is the reefer, industry shorthand for a refrigerated truck trailer or shipping container with its own self-contained diesel- or electric-powered cooling unit bolted to the front. A reefer isn't just an insulated box; it's actively refrigerating its cargo the entire time it's in motion, which is what lets it carry anything from frozen meat to standard-refrigeration vaccines across a continent without warming past its set point.

Refrigerated ocean shipping. For imported food, and for the raw pharmaceutical ingredients and bulk drug substances that get finished into medicines elsewhere, the reefer concept scales up into ocean freight: a standardized shipping container with the same kind of self-contained cooling unit, stacked by the thousands on purpose-built or retrofitted cargo ships. Reefer containers now handle the large majority of the world's seaborne refrigerated cargo, and the fleet, on the order of 1.6 million units globally, has been growing at roughly 5 percent a year, tracking rising international trade in fresh and frozen food.

Air freight. For anything genuinely high-value or time-critical, mostly finished pharmaceuticals and essentially all internationally distributed vaccines, the cold chain moves by air, trading a much higher cost for a shorter, more controllable window of exposure. Air shipments travel in one of two kinds of container. Active containers carry their own power source and mechanical cooling (compressor-based cooling and electric heating, or dry ice as the cold source), hold a precise target temperature, commonly 2 to 8C or a chosen point in between, for well over a hundred hours in some designs, and report their own status live. Passive containers are simpler and cheaper: well-insulated boxes with no power of their own, cooled entirely by gel packs, phase-change material, or dry ice packed around the product, with the packing itself engineered and tested rather than eyeballed. Active containers are reserved for the most valuable or sensitive freight; passive containers cover most of the rest, including a great deal of routine vaccine shipping.

Don't be confused: "active" and "passive" describe the container, not the product inside it. An active shipping container has its own power and cooling system and can hold a temperature for many hours on its own battery or generator. A passive one is just very good insulation around a pre-chilled refrigerant. Both are used constantly, often for the same kinds of products, because the choice is really about trip length, value, and how much it's worth paying to remove risk. A short domestic hop might ship the exact same vaccine in a passive box that a multi-day international route would put in an active one.

The last mile. The hardest, least standardized part of the whole chain is also the shortest: getting a vaccine or a temperature-sensitive drug from a regional or district store, which typically does have industrial cold rooms and generator backup, out to a small rural clinic or independent pharmacy that might not. This is where the cold chain shrinks down to a single small refrigerator, sometimes solar-powered where the electrical grid is unreliable or absent, and a health worker checking a thermometer or a VVM by hand, or carrying vaccines the final few miles in an insulated cold box packed with ice packs on a motorbike or on foot. It's the part of the system with the least redundancy and the most direct dependence on one person doing one routine task correctly, day after day.

The hidden workforce

A cold chain logistics specialist designs the actual route and packaging plan for a shipment, deciding, for a given product, distance, and budget, whether it travels by reefer truck or air, in an active or passive container, and with how much thermal buffer built in. Refrigerated truck drivers run the reefer fleet itself, and increasingly represent a distinct and harder-to-fill hiring category within trucking generally, since the job adds temperature checks, tighter delivery windows, and often overnight driving on top of the ordinary demands of the road. At the receiving end, pharmacists and clinic staff are legally and professionally responsible for what happens to a vaccine or drug once it's inside their own refrigerator, which is why vaccine storage and handling training is a routine part of running any clinic that stocks them. Quality assurance staff at distribution centers and manufacturers review a shipment's temperature logs before releasing the product for use or sale, a document-review job that has real teeth: a log showing an excursion outside the approved range can and does trigger a hold, an investigation, or a destruction order before a single dose reaches a patient. And biomedical equipment technicians maintain and calibrate the pharmaceutical-grade refrigerators, freezers, and cold rooms this whole system depends on, work that is far less visible than a delivery truck but just as load-bearing.

Where this came from

Mechanical cold chains for food and mechanical cold chains for medicine grew up decades, and in some ways a full century, apart, solving the same physical problem for very different reasons.

The food side came first. Shipping dressed meat any distance in the 1800s meant packing it in ice inside an ordinary boxcar, which worked poorly: meat sitting directly against ice discolored and picked up off flavors. Inventors tried fixes through the 1870s, including hanging carcasses on metal racks above the ice rather than resting them in it, but it was Chicago meatpacker Gustavus Swift, working with engineer Andrew Chase, who built the first genuinely practical version in 1878: an insulated boxcar with ice loaded through roof hatches, a sloped floor to drain meltwater, and overhead rails for hanging the meat clear of both the ice and its own drippings. Swift built a company, the Swift Refrigerator Line, around the design specifically because existing railroads, financially tied to shipping live cattle to Eastern slaughterhouses, refused to carry his refrigerated cars at all. Rival packers like Armour quickly copied the approach, and by the 1920s Swift's own fleet alone had grown past seven thousand cars, resupplied by icing stations built at division points along the rail lines. The refrigerated railcar, and the trucking version that gradually replaced it in the mid-1900s, is the direct ancestor of every reefer truck and container now moving food and medicine around the world.

The vaccine cold chain has a separate, more recent origin, tied to global public health rather than private industry. When the World Health Organization launched its Expanded Programme on Immunization in 1974, aiming to bring basic childhood vaccines to every country, it ran headlong into the same physical problem Swift had solved for beef almost a century earlier, except now the destination was often a village clinic with no reliable electricity at all. Early solutions were correspondingly improvised: kerosene-powered refrigerators and insulated ice-lined boxes carried vaccines the last stretch of the journey, workable but never fully reliable in tropical heat or genuinely remote settings. Refining that system, better refrigeration equipment, WHO-verified performance standards, and eventually solar power for locations with no grid at all, has been a slow, decades-long project rather than a single invention.

That project was tested at a scale nobody had planned for when the first mRNA COVID-19 vaccines arrived at the end of 2020, needing not the familiar 2 to 8C but -80C to -60C, the temperature of a specialized ultra-cold freezer rather than a village clinic's fridge. Pfizer's response was to build what its own staff called "freezer farms," warehouse floors the size of a football field packed with hundreds of ultra-cold units, at its Kalamazoo, Michigan plant among others, alongside a purpose-built shipping container that used continuously replenished dry ice to hold the temperature for up to about a month in transit. Hospitals and universities scrambled to build their own ultra-cold capacity overnight; the University of Arizona, to pick one widely reported example, opened a freezer farm sized to hold 1.6 million doses. It worked, but unevenly, favoring wherever ultra-cold freezers, or the money to get them fast, already existed.

Standards and coordination

Nothing about a cold chain works across borders and companies without a shared, enforced rulebook. The World Health Organization sets cold chain guidance and equipment prequalification standards (PQS) used by international immunization programs: performance specifications that any refrigerator, freezer, cold room, or temperature monitoring device has to meet before UN agencies and most national vaccination programs will buy it, covering everything from how well a solar-powered clinic fridge holds temperature through a cloudy week to how a data logger has to report an excursion. In the United States, pharmaceutical distribution more broadly falls under FDA Good Distribution Practice requirements, embedded partly in manufacturing regulations (21 CFR Part 211) and partly in the Drug Supply Chain Security Act, which requires products to be serialized and tracked at every change of custody. The European Union runs a parallel but separately codified system, the EU Good Distribution Practice guideline, first issued in 1994 and substantially rewritten in 2013, which requires any company handling medicines at the wholesale level to hold a distribution authorization and to verifiably control temperature, humidity, and traceability at every warehouse, vehicle, and transfer point in its network. For air freight specifically, the International Air Transport Association (IATA) publishes Temperature Control Regulations covering how temperature-sensitive healthcare cargo must be labeled, packed, and handled, alongside separate dangerous goods rules governing dry ice itself (classified UN 1845, and capped at 2.5 kilograms per package on passenger flights, far more on cargo-only aircraft, because dry ice sublimates directly into carbon dioxide gas that can build up dangerous concentrations in an enclosed aircraft hold if it isn't vented and handled correctly). IATA's CEIV Pharma program, running since 2014, independently certifies airlines, airports, and freight handlers against these standards through multi-day, on-site audits.

Every one of these frameworks converges on the same practical requirement: a documented, auditable temperature excursion protocol. If a shipment's logger or VVM shows the product went outside its approved range, the product cannot simply continue on to a patient. It has to be quarantined, labeled, and reviewed, typically by the manufacturer, against real stability data for that specific product and that specific excursion, a process that can end in the shipment being released as still usable, or in its outright destruction. The paperwork trail is not bureaucratic overhead layered on top of the cold chain; it's the actual mechanism by which a temperature failure gets caught before it reaches someone's arm.

Keeping it working

Reliability here is a maintenance calendar as much as a piece of equipment. Thermometers and data loggers need periodic calibration against a certified reference standard, because a logger that drifts out of calibration can silently misreport a real excursion as normal, or the reverse. Reefer trucks and stationary cold storage units go through scheduled preventive maintenance on their compressors and refrigerant systems, the same category of mechanical wear covered in Chapter 8's look at a home refrigerator's compression cycle, just running continuously and under far less forgiving conditions. Cold storage facilities, and increasingly clinics that stock vaccines, keep backup generators, tested on a regular schedule, for the same reason a municipal water or sewer system does: a compressor that loses power for too long doesn't pause gracefully, it just starts warming (see Chapter 5 on how that backup power itself gets generated and switched over). And clinics and pharmacies are subject to routine cold chain audits, unannounced or scheduled inspections that check logbooks, thermometer placement, and door-seal condition against program requirements, because the single most common source of a real excursion isn't a failed compressor. It's a door that didn't fully close, or a full box loaded in front of the fan.

When it breaks

Most documented cold chain failures are mundane, which is exactly what makes them hard to prevent. In Boston in January 2021, a building cleaner accidentally unplugged a freezer holding Moderna COVID-19 vaccine, spoiling roughly 1,900 doses before anyone caught it. Around the same period, Tennessee's health department reported close to 5,000 discarded doses after a different storage failure, Florida providers reported a mobile refrigeration unit that had simply been switched off, and Connecticut providers caught a refrigerator door that hadn't sealed properly in time to save the doses inside. None of these involved anything exotic: no cyberattack, no design flaw, just an ordinary piece of equipment behaving normally in response to an ordinary human mistake. Zoomed out to the national level, an NBC News analysis of federal data found that the United States discarded about 82.1 million COVID-19 vaccine doses, roughly 11 percent of everything distributed, between December 2020 and mid-2022, spoilage from power and equipment failures alongside plain expiration and unused partial vials.

Food shipments fail the same way, just with different regulators reading the aftermath. In 2018, Target Corporation recalled frozen ready-to-eat and not-ready-to-eat meat and poultry products from a single Hawaii store after temperature records from the shipping carrier showed the load had warmed in transit, creating conditions where bacteria like Bacillus cereus and Staphylococcus aureus could grow enough to cause food poisoning: an ordinary reefer unit underperforming for long enough to matter, caught only because someone downloaded the log afterward.

The mRNA COVID-19 vaccine's original ultra-cold requirement was, in its own right, a distinct and much larger-scale failure risk, not because the freezers themselves broke down often, but because so few of them existed outside wealthy countries when the vaccine launched. As of early November 2021, fewer than 35 million of the more than 7 billion COVID-19 vaccine doses administered worldwide had gone into arms in low-income countries, and by the end of that year fewer than one in ten African nations were on pace to have fully vaccinated 40 percent of their population, a gap that health researchers tie only partly to vaccine supply and partly, directly, to the ultra-cold storage and transport infrastructure that simply hadn't existed anywhere near the last mile.

The scale of it

The global cold chain logistics market, spanning food and pharmaceuticals together, was valued at somewhere around 370 to 430 billion dollars across different industry estimates for the mid-2020s, and has been growing on the order of 13 to 15 percent a year, driven by rising international trade in fresh food and by pharmaceutical and biologic drugs that increasingly need refrigeration by design. UNICEF alone, acting as the world's largest single vaccine buyer, ships close to three billion doses a year to more than a hundred countries, almost entirely by air for decades running (it completed its first-ever vaccine shipment by refrigerated cargo ship only in July 2025, a 500,000-dose delivery to Ivory Coast chosen specifically to test whether sea freight could cut both emissions and cost on routes where speed matters less). At the height of the COVID-19 response, Gavi's Cold Chain Equipment Optimization Platform, a roughly 250-million-dollar effort running since 2017, had delivered more than 15,300 solar-powered vaccine refrigerators to three dozen African countries, in the Democratic Republic of Congo alone lifting the share of rural health centers with a working vaccine fridge from about 16 percent in 2016 to close to 80 percent within a few years. And globally, something on the order of 1.6 million refrigerated shipping containers now move a growing share of the world's seaborne perishable trade, a fleet that barely existed in its current form when Swift's first refrigerator car left Chicago in 1878.

Trade-offs and what's next

The most direct long-term fix for the cold chain's weakest points isn't more refrigeration. It's needing less of it in the first place. Cold storage and transport reportedly account for a large share, by some industry estimates as much as 80 percent, of the total cost of running a vaccination program in a lower-income country, which is why the World Health Organization named thermostable vaccines, formulations engineered to survive well outside the standard 2 to 8C range, a priority research area for over a decade. Progress has been real but uneven: some existing vaccines, including certain cholera and meningococcal A formulations, already tolerate ambient heat far better than most, and newer formulation techniques like spray- drying have produced experimental vaccines stable for months at temperatures that would ruin a conventional one within hours. None of this has yet produced a widely licensed replacement for the vaccines that still need the full cold chain, but it is the one line of research that could shrink the entire system rather than just monitor it more closely.

Monitoring itself is also shifting, from passive to active. Chemical indicators like the VVM and old-style data loggers report only after the fact, or only when someone physically checks them; a shipment can fail quietly for hours before anyone downstream knows to ask. Real-time IoT sensors, now standard on premium air freight containers and increasingly common on ordinary reefer trucks, push that same information out continuously, letting a quality assurance team catch a drifting temperature and intervene before a shipment is ruined rather than after, which several industry estimates tie to double-digit percentages of biologic shipments still lost to cold chain failures every year under older, less immediate monitoring.

None of this closes the gap between wealthy and lower-income regions on its own. Ultra-cold freezers, active air-cargo containers, and networked sensors are all substantially more expensive than the equipment they replace, and the countries least able to absorb that cost are frequently the same ones with the least reliable electrical grids underneath the whole system, whatever generation of equipment sits on top of it. Solar-powered clinic refrigerators have closed part of that gap over the past decade, but they solve the last mile, not the ultra-cold freezer farm several steps earlier in the chain. Whichever mechanism eventually narrows that gap further, more thermostable formulations that need less cooling everywhere, or continued buildout of the cooling infrastructure itself, is still an open race, not a settled outcome.

Back to the counter

That flu shot, or that bag of frozen peas, arrived exactly the way it did because a chain of trucks, ships, warehouses, and one small refrigerator behind a counter held its temperature the entire way, verified at every handoff by a sticker, a logger, or a sensor that most people never look at and were never meant to. None of it announced itself. A vaccine that had failed somewhere along that chain would have looked, in your pharmacist's hand, exactly like one that hadn't, which is the entire reason this system is instrumented as heavily as it is: not because failure is loud, but because it's silent, and the only way to catch a silent failure is to measure constantly and trust the measurement over your own eyes.

The leap: what it replaced, and the work behind it

For most of human history, cold was a thing you got in winter and lost in summer, which meant food and medicine could only travel as far as they could last unspoiled. Meat was salted until it was more salt than meat. Sailors got scurvy because fresh fruit rotted before the voyage ended. And the danger wasn't only spoilage you could taste. Raw milk, hauled warm from cow to city, carried bovine tuberculosis: an epidemic of it in the early 1900s is estimated to have killed about 65,000 people over 25 years in the United States from contaminated dairy alone. In 1891, bad milk was linked to roughly 23 percent of deaths among children under three in New York City. When the city began pasteurizing milk in 1912, deaths from the non-lung form of tuberculosis that milk carried fell from 1,107 in 1921 to 12 by 1953. Refrigeration and pasteurization together, cold plus heat, turned a food that regularly killed children into one nobody thinks twice about.

The vaccine side of this is younger and, in its way, larger. When the World Health Organization launched its immunization program in 1974, fewer than 5 percent of the world's infants could get routine childhood shots, in part because the vaccines couldn't survive the trip to where the children were. Building a cold chain that reached the last village fixed that. The Lancet's 50-year accounting, published in 2024, credits vaccination since 1974 with averting about 154 million deaths, 146 million of them children under five, most of those infants. None of those doses would have worked if they'd cooked in transit. Keeping them cold is not a one-time achievement but a daily one: UNICEF alone moves close to three billion doses a year, and behind them stands a workforce most people never picture, from the tens of thousands of refrigerated-truck drivers hauling temperature-controlled loads across the U.S. to the clinic nurse who checks a vaccine vial monitor by hand before every injection.

You touch this system more days than you'd guess. The yogurt that's still good, the chicken that doesn't make you sick, the insulin that still lowers blood sugar, the flu shot that actually builds immunity: each arrived through an unbroken run of cold that nobody advertised. Picture the morning it fails. Not a dramatic blackout, just a warehouse freezer that drifted overnight, a reefer unit that quit on a hot interstate, a clinic fridge unplugged by a cleaner. In Boston in January 2021, that last one spoiled about 1,900 doses of Moderna vaccine before anyone noticed. The food you'd throw out; you'd taste it or smell it. The medicine is worse, because a heat-killed vaccine looks and injects exactly like a good one, and the failure only shows up later as the disease it was supposed to stop. Every cold thing you take for granted is somebody, right now, watching a number so you don't have to.

Real-world examples and recent developments

The companies, devices, and programs below are real, currently operating pieces of the cold chain described in this chapter.

  • Lineage, Inc. (public since July 25, 2024): the world's largest temperature-controlled warehouse operator, with more than 480 facilities across North America, Europe, and Asia. Its Nasdaq debut that July raised $4.4 billion and was, at the time, the largest REIT initial public offering on record. CNBC, on Lineage's IPO
  • Americold Realty Trust: the world's second-largest cold storage REIT, operating 231 warehouses with about 1.4 billion cubic feet of refrigerated space across North America, Europe, Asia-Pacific, and South America as of the end of 2025. Wikipedia, on Americold
  • va-Q-tec (founded 2001, Germany): a manufacturer of vacuum-insulation-panel passive shipping containers, such as the va-Q-tainer and va-Q-case, that move pharmaceuticals and clinical trial materials without any onboard power source. va-Q-tec, Healthcare and Logistics
  • World Courier, a Cencora (formerly AmerisourceBergen) subsidiary: a specialty pharmaceutical logistics company that in December 2023 announced new U.S. transport stations equipped with liquid nitrogen charging capability, expanding cryogenic cold chain handling for cell and gene therapies. Cencora, on World Courier's expansion
  • Zipline: a drone delivery company that began flying blood and vaccines to rural clinics from a Rwandan distribution center in 2016, then expanded into Ghana in 2019 and several other African countries; it has since delivered more than 23 million vaccine doses by drone. Gavi, on Zipline's reach
  • ColdTrace, made by Nexleaf Analytics: a remote vaccine-fridge temperature monitoring device rolled out across 43 countries between 2021 and 2025 with Gavi's support, credited with up to an 80 percent reduction in vaccine losses at the clinics that use it. Gavi, on cold chain equipment deployment

Recent developments

  • Americold-EQT cold storage joint venture (announced May 2026): Americold agreed to contribute 12 of its cold storage facilities, valued at more than $1.3 billion, to a new North American joint venture with the investment firm EQT, continuing a wave of consolidation among the largest cold storage operators. Americold, on the EQT joint venture
  • Zipline's $150 million U.S. State Department partnership (announced November 25, 2025): a pay-for-performance grant meant to roughly triple Zipline's drone delivery network across Ivory Coast, Ghana, Kenya, Nigeria, and Rwanda, reaching up to 15,000 health facilities and as many as 130 million people. Zipline newsroom
  • Thermostable mRNA vaccine research (2025): researchers have published preclinical work on lyophilized (freeze-dried) self-replicating mRNA vaccines and lipid-free, spray-dried formulations designed to survive at refrigerator or even room temperature, aimed directly at removing the ultra-cold requirement described earlier in this chapter. Taylor & Francis, on mRNA vaccine thermostability

Glossary

Cold chain. An unbroken sequence of temperature-controlled storage and transport maintaining a product within a defined range from manufacture to use.

Temperature excursion. An event where a product's temperature moves outside its approved range, triggering a mandatory review before the product can be used or released.

Data logger. An electronic device that records ambient temperature at set intervals throughout storage or transport, producing a reviewable or real-time record.

Vaccine vial monitor (VVM). A heat-sensitive sticker attached directly to a vaccine vial that darkens irreversibly with cumulative heat exposure, independent of any separate thermometer reading.

Reefer. A refrigerated truck trailer or shipping container with its own self-contained, actively powered cooling unit.

Active container. A shipping container with its own power source and mechanical cooling system, able to hold a precise temperature for many hours independently.

Passive container. An insulated shipping container with no power of its own, cooled entirely by pre-chilled gel packs, phase-change material, or dry ice packed around the product.

Good Distribution Practice (GDP). The body of regulatory requirements, enforced separately by agencies like the FDA and EMA, governing how medicines must be stored, transported, and documented to preserve their quality between manufacturer and patient.

Last mile. The final, typically least standardized leg of a cold chain, moving a product from a regional store to its point of use, such as a rural clinic or small pharmacy.

WHO PQS (Prequalification of medical products). A World Health Organization program that sets and verifies performance standards for cold chain equipment, including refrigerators, freezers, cold rooms, and temperature monitoring devices, used by international immunization programs.

Solar direct-drive refrigerator. A vaccine refrigerator powered directly by solar panels without a battery bank, designed for clinics with unreliable or absent grid electricity.

Ultra-cold storage. Storage at roughly -60C to -80C, required by the original formulation of the Pfizer-BioNTech mRNA COVID-19 vaccine and by some other biologics and lab specimens.

IATA Temperature Control Regulations. International Air Transport Association rules governing how temperature-sensitive cargo must be labeled, packed, and handled on commercial aircraft.

Thermostable vaccine. A vaccine formulated to remain effective outside the standard 2 to 8C refrigerated range, reducing or removing the need for cold chain handling.

Sources and notes

Open questions

  • Estimates of the global cold chain market's exact size vary by more than 50 billion dollars between research firms depending on what activities are counted; treat any single figure in this chapter as representative of a range, not an exact industry-wide total.
  • Public reporting has not settled on an exact global count of ultra-cold freezers built specifically for COVID-19 vaccine distribution between 2020 and 2021; the Pfizer and University of Arizona examples here are illustrative, well-documented cases rather than a full census.
  • How quickly thermostable vaccine formulations reach wide licensure, and how much they actually shrink the infrastructure gap between wealthy and lower-income regions, remains an open, actively researched question.

Next, the cold chain gets a shipment safely to its destination. Getting it through the intersection along the way is its own hidden system. How traffic lights coordinate an intersection 👉